Interleukin-10-treated human dendritic cells induce a melanoma-antigen- specific anergy in CD8+ T cells resulting in a failure to lyse tumor cells

Blood

Volumn 93, Issue 5, 1999, Pages 1634-1642

  Steinbrink, Kerstin ^a   Jonuleit, Helmut ^b   Müller, Gabriele ^b   Schuler, Gerold ^b   Knop, Jürgen ^b   Enk, Alexander H ^b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; CYTOKINE; HLA A2 ANTIGEN; INTERLEUKIN 10; MELANOMA ANTIGEN; MONOPHENOL MONOOXYGENASE;

ARTICLE; CLONAL ANERGY; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; CYTOTOXICITY; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOSURVEILLANCE; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR CELL;

EID: 0033105695     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.5.1634     Document Type: Article

References (43)

1. Steinman RM: The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9:271, 1991
2. Hoefsmit ECM, Duijvestin AM, Kamperdijk WA: Relation between Langerhans cells, veiled cells, and interdigitating cells, Immunobiology 161:255, 1982
3. Austyn JM, Kupiec-Weglinski JW, Hankins DF, Morris PJ: Migration patterns of dendritic cells in the mouse. Homing to T-cell-dependent areas of spleen and binding within marginal zones. J Exp Med 166:646, 1988
4. Larsen CP, Steinman RM, Witmer-Pack MD, Hankins DF, Morris PJ, Austyn JM: Migration and maturation of Langerhans cells in skin transplants and explants. J Exp Med 172:1483, 1990
5. Schuler G, Steinman RM: Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J Exp Med 161:526, 1985
6. Steinman RM, Young JW: Signals arising from antigen-presenting cells. Curr Opin Immunol 3:361, 1991
7. + T lymphocytes by human blood dendritic cells in vitro. J Clin Invest 90:229, 1992
8. Schreiber H: Tumor immunology, in Paul WE (ed): Fundamental Immunology (ed 3). New York, NY, Raven, 1993, p 1143
9. Kim J, Modlin RL, Moy RL, Dubinet SM, McHugh T, Nickoloff BJ, Uyemura K: IL-10 production in cutaneous basal and squamous cell carcinomas: A mechanism for evading the local T cell immune response. J Immunol 155:2240, 1995
10. Gastl GA, Abrams JS, Nanus DM, Osterkamp R, Silver J, Liu F, Chen M, Albino AP, Bander N: Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression. Int J Cancer 55:96, 1993
11. Pisa P, Halapi E, Pisa EK, Gerdin E, Hising C, Bucht A, Gerdin B, Kiessling R: Selective expression of interleukin-10, interferon-γ, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies. Proc Natl Acad Sci USA 89:7708, 1991
12. Burdin N, Peronne C, Banchereau J, Rousset F: Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10. J Exp Med 177:295, 1993
13. Merlo A, Juretic A, Zuber M, Filgueira L, Luscher U, Caetano V, Ulrich J, Gratzl O, Heberer M, Spagnoli GC: Cytokine gene expression in primary brain tumors, metastases and meningiomas suggests specific transcription patterns. Eur J Cancer 70:1182, 1993
14. Smith D R, Kunkel SL, Burdick MD, Wilke CA, Orringer MB, Whyte RI, Strieter RM: Production of interleukin-10 by human bronchogenic carcinoma. Am J Pathol 145:18, 1994
15. Lattime E, Mastrangelo M, Bagasra O, Li W, Berd D: Expression of cytokine mRNA in human melanoma tissues. Cancer Immunol Immunother 41:151, 1995
16. Chen Q, Daniel V, Mahrer D, Hersey P: Production of IL-10 by melanoma cells: Examination of its role in immunosuppression mediated by melanoma. Int J Cancer 56:755, 1994
17. Kru̇ger-Krasagakis S, Krasagakis K, Garbe C, Schmitt E, Huls C, Blankenstein T, Diamantenstein T: Expression of interleukin-10 in human melanoma. Br J Cancer 70:1182, 1994
18. Dummer W, Becker JC, Schwaaf A, Leverkus M, Moll T, Bröcker EB: Elevated serum levels of interleukin-10 in patients with metastatic melanoma. Melanoma Res 5:67, 1995
19. Dummer W, Bastian BC, Ernst N, Schänzle C, Schwaaf A, Bröcker EB: Interleukin-10 production in malignant melanoma: Preferential detection of IL-10-secreting tumor cells in metastatic lesions. Int J Cancer 66:607, 1996
20. Enk AH, Jonuleit H, Saloga J, Knop J: Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma. Int J Cancer 73:309, 1997
21. de Waal Malefyt RW, Yssel H, Roncarolo MG, Spits H, de Fries JE: Interleukin-10. Curr Opin Immunol 4:314, 1992
22. Hsu DH, Oore KW, Spits H: Differential effects of interleukin-4 and -10 on interleukin-2-induced interferon-γ synthesis and lymphockine-activated killer activity. Int Immunol 4:563, 1992
23. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, O'Garra A: IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 146:3444, 1991
24. Willems F, Marchant A, Delville JA, Gérard C, Delvaux A, Velu T, de Boer M, Goldman M: Interleukin-10 inhibits B7 and intercellular molecule-1 expression on human monocytes. Eur J Immunol 24:1007, 1994
25. de Waal Malefyt RW, Haanen J, Spits H, Roncarolo MG, te Velde A, Figdor C, Johnson K, Kastelein R, Yssel H, de Vries JE: Interleukin-10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by dimishing the antigen-capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 174:915, 1991
26. de Waal Malefyt R, Abrams J, Bennet B, Figdor CG, de Fries JE: Interleukin-10 (IL-10) inhibts cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209, 1991
27. Fiorentino DF, Zlotnik A, Mosman TR, Howard M, O'Garra A: IL-10 inhibits cytokine production by activated macrophages. J Immunol 147:3815, 1991
28. Bogdan C, Nathan C: Modulation of macrophage function by transforming growth factor beta, interleukin-4, and interleukin-10. Ann NY Acad Sci 685:713, 1993
29. Beissert S, Hosoi J, Grabbe S, Asahina A, Granstein RD: IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells. J Immunol 154:1280, 1995
30. Enk AH, Angeloni VL, Udey MC, Katz SI: Inhibition of Langerhans cell antigen-presenting function by IL-10. J Immunol 151:2390, 1993
31. Steinbrink K, Wölfl M, Jonuleit H, Knop J, Enk AH: Induction of tolerance by interleukin-10-treated dendritic cells. J Immunol 159:4772, 1997
32. Romani N, Gruner S, Brang D, Kämpken E, Lenz A, Trockenbacher B, Konwalinka G, Fritsch PO, Steinman RM, Schuler G: Proliferating dendritic cell progenitors in human blood. J Exp Med 180:83, 1994
33. Jonuleit H, Kühn U, Müller G, Steinbrink K, Schmidt E, Knop J, Enk AH: Proinflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under FCS-free conditions: Effect of culture conditions on the type of T cell response. Eur J Immunol 27:3135, 1997
34. Salazar-Onfray F, Petersson M, Franksson L, Matsuda M, Blankenstein T, Kärre K, Riesling R: IL-10 converts mouse lymphoma cells to a CTL-resistant, NK-sensitive phenotype with low but peptide-inducible MHC class I expression. J Immunol 154:6291, 1995
35. Matsuda M, Salazar F, Petersson M, Masucci G, Hansson J, Pisa P, Zhang QJ, Masucci M, Kiessling R: Interleukin-10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression. J Exp Med 180:2371, 1994
36. Rohrer JW, Coggin JH: CD8 T cell clones inhibit antitumor T cell function by secreting IL-10. J Immunol 155:5719, 1995
37. Qin Z, Noffz G, Mohaupt M, Blankenstein T: Interleukin-10 prevents dendritic cell accumulation and vaccination with GM-CSF gene-modified tumor cells. J Immunol 195:770, 1997
38. Hagenbaugh A, Sharma S, Dubinett SM, Wie Sh-Y, Aranda R, Cheroutre H, Fowell DJ, Binder S, Tsao B, Locksley RM, Moore KW, Kronenberg M: Altered immune responses in interleukin-10 trangenic mice. J Exp Med 185:2101, 1997
39. Zheng LM, Ojcus DM, Garaud F, Roth C, Maxwell E, Li Z, Rong H, Chen J, Wang XY, Catino JJ, King I: Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism. J Exp Med 184:579, 1996
40. Berman RM, Suzuki T, Tahara H, Robbins PD, Narula SK, Lotze MT: Systemic administration of cellular IL-10 induces an effective, specific and long-lived immune response against established tumors in mice. J Immunol 157:231, 1996
41. Giovarelli M, Musani P, Modesti A, Dellabona P, Casorati G, Allione A, Consalvo M, Cavallo F, di Pierro F, De Giovanni C, Musso T, Forni G: Local release of IL-10 by transfected mouse mammary adenocarcinoma cells dos not suppress but enhances antitumor reaction and elicts a strong cytotoxic lymphocyte and antibody-dependent immune memory. J Immunol 155:3112, 1995
42. Gérard CM, Bruyns C, Delvaux A, Baudson N, Dargent JL, Goldman M, Velu T: Loss of tumorigenicity and increased tumorgenicity induced by interleukin-10 gene transfer in B16 melanoma cells. Hum Gene Ther 7:23, 1996
43. Suzuki T, Tahara H, Narula S, Moore KW, Robbins PD, Lotze MT: Viral interleukin-10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors. J Exp Med 182:477, 1996